Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.

Source:http://linkedlifedata.com/resource/pubmed/id/18375438

Download in:

View as

General Info

PMID
18375438